The geopolitical landscape faces a recalibration as President Trump shifts from active military escalation to a long-term strategy of economic attrition against Iran following reports of depleted precision munitions, while simultaneously seeking a summit with North Korea and reducing joint drills with Seoul. Domestically, the administration's trajectory is reinforced by the selection of Dr. Heidi Overton to lead the FDA, a choice signaling continued focus on second-term health policy goals, including vaccine reform. These moves coincide with Trump's provocative claims regarding the Census Bureau identifying 24,000 non-citizen voters in 2020—an analysis he asserts will expand as more records are reviewed. Amidst this executive activity, Democratic leadership has hardened its stance on the judiciary; House Minority Leader Hakeem Jeffries signaled a formal shift toward pursuing structural Supreme Court reform, including potential expansion and term limits, framing the body as a partisan entity. Global markets are exhibiting acute sensitivity to these tensions and underlying macroeconomic pressures, exemplified by the KOSPI index briefly halting after a 5% drop sparked by a tumble in chip heavyweights like Samsung and SK Hynix. This weakness in the semiconductor and broader tech sector—compounded by rising oil prices and Treasury yields—is weighing on Asian currencies and contrasting with the resilient, idiosyncratic performance of select Australian firms, such as Evolution Mining and Service Stream, which posted dividend hikes or growth on specific defense sector entries. Meanwhile, corporations continue to navigate a changing landscape: packaged food manufacturers are actively adjusting to the demand-destruction threat posed by GLP-1 weight-loss drugs, while tech firms are attempting to quell public backlash regarding data center expansion through job guarantees and outreach.